Skip to main content
Premium Trial:

Request an Annual Quote

Michael Olex, Mark Philip

Premium
RainDance Technologies this week announced the appointment of Michael Olex as vice president of system development, effective immediately.
 
Olex joins RainDance from BioTrove, where he was vice president of manufacturing, and established the company's OpenArray consumable and instrumentation manufacturing departments. He also served as senior vice president at US Genomics; president of International Light; director of business projects at Applied Biosystems; and vice president of manufacturing at PerSeptive Biosystems
 

 
Mark Philip has been appointed the new president and chief executive officer of Znomics, the company announced this week. He succeeds Richard Sessions, Znomics co-founder and interim CEO, who will remain as a consultant to the company and as an active member of Znomics' board of directors.
 
Philip was most recently president of Stryker Biotech. Prior to Stryker Biotech, he was president and chief executive officer of Zycos. Philip previously served as president and chief executive officer of Immuno-US. Prior to Immuno-US, he held a number of international executive management positions at Baxter International in Europe, the US, and Japan, before which he was employed by Schering-Plough Pharmaceuticals.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.